Forbes contributors publish independent expert analyses and insights. I focus on new drugs and innovations in medical devices. Last week, the FDA approved XCOPRI (cenobamate tablets) to treat ...
Brain CT shows right temporal lobe epilepsy with hypometabolism. Seizures in the elderly often mimic other conditions, such as transient ischemic attack or dementia. Don't be fooled into a ...
Since 1983, eight new AEDs have been introduced (see Table 2 below). Sadly, a recent VA study of more than 21,000 subjects aged 65 years and older revealed that 80% were being treated with ...
Sabril approved for infantile spasms and adult epileptic seizures The FDA has approved Sabril (vigabatrin, from Lundbeck) oral solution as monotherapy for infantile spasms in children 1 month to 2 ...
Post-hoc analysis from open-label Phase 3 study shows treatment with cenobamate led to a reduction of concomitant anti-seizure medications (ASMs) while maintaining ≥50% and 100% seizure reduction ...
Epilepsy is the world's most common chronic neurological condition, affecting about 1 in every 100 people. Those who have it ...
Treatment with vigabatrin carries the risk of permanent vision loss. The Food and Drug Administration (FDA) has expanded the approval of Sabril® (vigabatrin; Lundbeck) to include treatment of ...
U.S. Rep. John Larson, D-1st District, suffered a “complex partial seizure” that caused him to freeze and abruptly stop speaking while delivering a floor speech on Monday, according to a statement ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback